ArticleAntibiotics (Basel, Switzerland)2022

Factors Influencing Disease Stability and Response to Tocilizumab Therapy in Severe COVID-19: A Retrospective Cohort Study.

Wael Hafez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.